Article
Demichev V, Tober-Lau P, Lemke O, Nazarenko T, Thibeault C, Whitwell H, Röhl A, Freiwald A, Szyrwiel L, Ludwig D, Correia-Melo C, Aulakh SK, Helbig ET, Stubbemann P, Lippert LJ, Grüning NM, Blyuss O, Vernardis S, White M, Messner CB, et al., Ralser M and Kurth F
Cell Systems
The study combines dense clinical sampling with quantitative proteomics to follow disease over time and construct prognostic molecular maps.
It establishes the value of repeated, high-throughput blood-proteome measurements for patient stratification and prognosis.
Back to news